Vivid BioInnovations, PBC

Funding and NIH signals

• NIH award NIH awarded $506K (SBIR Phase II 1R44AG102286-01, new, notice Sep 8, 2026); 7 NIH awards totaling $3.76M in the last 12 months. NIH RePORTER 1R44AG102286-01 (Sep 8, 2026)
  Evidence (7 events)

  • Sep 8, 2026 · NIH RePORTER 1R44AG102286-01
    Organization: VIVID BIOINNOVATIONS, PBC; City/State: San Francisco, CA; Project number: 1R44AG102286-01; Activity code: R44; Fiscal year: 2026; Award notice date: 2026-09-08; FY total cost (award amount): 506495; Administering IC: National Institute on Aging; Project title: AstroTarget™ Astro-Enrichment Kit: A Microfluidic-Free Platform for High-Throughput Rare-Astrocyte Isolation and Multi-Omic Profiling from Frozen Alzheimer’s Brain; Organization type: Domestic For-Profits
  • Aug 27, 2026 · NIH RePORTER 4R44AG091101-02
    Organization: VIVID BIOINNOVATIONS, PBC; City/State: San Francisco, CA; Project number: 4R44AG091101-02; Activity code: R44; Fiscal year: 2026; Award notice date: 2026-08-27; FY total cost (award amount): 1012648; Administering IC: National Institute on Aging; Project title: FIND-seq: A Novel Cell Sorting Technology to Enable Investigation of Rare Cells in Primary Human Tissues; Organization type: Domestic For-Profits
  • Aug 20, 2026 · NIH RePORTER 4R44GM161309-02
    Organization: VIVID BIOINNOVATIONS, PBC; City/State: San Francisco, CA; Project number: 4R44GM161309-02; Activity code: R44; Fiscal year: 2026; Award notice date: 2026-08-20; FY total cost (award amount): 1027505; Administering IC: National Institute of General Medical Sciences; Project title: A Universal Platform for Ultrahigh-Throughput Biocatalyst Evolution With micro-Mass Spectrometry; Organization type: Domestic For-Profits
  • Aug 19, 2026 · NIH RePORTER 1R44AI195215-01
    Organization: VIVID BIOINNOVATIONS, PBC; City/State: San Francisco, CA; Project number: 1R44AI195215-01; Activity code: R44; Fiscal year: 2026; Award notice date: 2026-08-19; FY total cost (award amount): 307074; Administering IC: National Institute of Allergy and Infectious Diseases; Project title: HIVE-seq: A Novel Omics Technology to Profile Thousands of Single HIV-Positive Cells; Organization type: Domestic For-Profits
  • Aug 19, 2026 · NIH RePORTER 1R44AI197850-01
    Organization: VIVID BIOINNOVATIONS, PBC; City/State: San Francisco, CA; Project number: 1R44AI197850-01; Activity code: R44; Fiscal year: 2026; Award notice date: 2026-08-19; FY total cost (award amount): 299991; Administering IC: National Institute of Allergy and Infectious Diseases; Project title: Spatially Resolved Single-Cell DNA Sequencing: A General Spatial Genomics Platform with Application to HIV Reservoir Mapping; Organization type: Domestic For-Profits
  • Aug 7, 2026 · NIH RePORTER 1R44CA310740-01
    Organization: VIVID BIOINNOVATIONS, PBC; City/State: San Francisco, CA; Project number: 1R44CA310740-01; Activity code: R44; Fiscal year: 2026; Award notice date: 2026-08-07; FY total cost (award amount): 306872; Administering IC: National Cancer Institute; Project title: Ultrahigh-Throughput Cell Interaction Screening to Advance CAR-T Therapeutic Development; Organization type: Domestic For-Profits
  • Aug 4, 2026 · NIH RePORTER 1R44GM163514-01
    Organization: VIVID BIOINNOVATIONS, PBC; City/State: San Francisco, CA; Project number: 1R44GM163514-01; Activity code: R44; Fiscal year: 2026; Award notice date: 2026-08-04; FY total cost (award amount): 300001; Administering IC: National Institute of General Medical Sciences; Project title: Integrated High-Throughput Microfluidic-Mass Spectrometry for Enhanced Biomedical Data Generation and AI Model Training; Organization type: Domestic For-Profits

Job counts as of Oct 18, 2026. All funding and NIH signals